Business Context and Reporting Period
Company: Community Health Systems, Inc. (CYH)
Filing Type: Form 8-K (Current Report)
Date: January 15, 2020
Context: The filing was issued in advance of the Company's presentation at the 38th Annual J.P. Morgan Healthcare Conference. It provides preliminary 2020 guidance and an update on 2019 Adjusted EBITDA expectations.
Key Financial Metrics and Guidance
2019 Full-Year Outlook:
- Adjusted EBITDA: Management anticipates full-year 2019 Adjusted EBITDA will be toward the middle portion of the previously issued guidance (from the October 29, 2019 earnings release).
- Net Operating Revenues: $12.4 billion to $12.8 billion.
- Same-Store Adjusted Admissions: Expected to increase 1.5% to 2.5% compared to 2019.
- Adjusted EBITDA: $1.65 billion to $1.80 billion.
- The 2020 guidance reflects the impact of anticipated divestitures occurring in 2020.
- The filing does not provide a reconciliation of projected 2020 Adjusted EBITDA to net income (loss) at this time due to the difficulty in quantifying reconciling items on a forward-looking basis.
Material Changes and Strategic Initiatives
Portfolio Rationalization: The Company continues to execute on a portfolio rationalization and deleveraging strategy, which includes the disposition of hospitals and non-hospital businesses. The 2020 guidance explicitly accounts for anticipated divestitures.
Margin Initiatives: Management expects to continue executing on previously stated margin initiatives to support the projected Adjusted EBITDA range.
Outlook, Risks, and Contingencies
Management Commentary: The Company intends to provide updated 2020 annual earnings guidance and final reporting for the three months and year ended December 31, 2019, on a future date. Current figures are based on information available as of January 15, 2020, and are subject to revision.
Key Risks and Uncertainties:
- Debt and Liquidity: Risks associated with substantial indebtedness, leverage, and debt service obligations, including the ability to refinance maturing debt and remain in compliance with covenants.
- Regulatory Environment: Impact of federal and state health reform initiatives, potential changes to the Affordable Care Act, and Medicaid program support.
- Reimbursement: Changes in Medicare/Medicaid payment levels, commercial payor rates, and contract terms.
- Legal and Compliance: Potential adverse impacts from government investigations, audits, False Claims Act litigation, and professional liability claims.
- Operational: Risks related to cyber-attacks, infectious disease outbreaks, and the ability to attract and retain qualified personnel.
Investor Verification Checklist
- Divestiture Timing: Verify the specific timing and financial impact of the anticipated 2020 divestitures included in the guidance.
- Debt Maturity Profile: Review the Company's upcoming debt maturities and refinancing plans given the highlighted risk of substantial indebtedness.
- Reconciliation Data: Await the future filing that will reconcile the non-GAAP Adjusted EBITDA guidance to GAAP net income.
- 2019 Final Results: Monitor the upcoming release of final financial results for the year ended December 31, 2019, to confirm the "middle portion" Adjusted EBITDA expectation.
- Regulatory Changes: Assess the potential impact of ongoing legislative changes to the Affordable Care Act and Medicaid on reimbursement rates.